semaglutide info GLP-1 Treatment Specialist Semaglutide for Weight Loss: How

Some research is looking into whether less frequent injections can be just as beneficial

Exclusion criteria included a history of self-reported eating disorders (eg, anorexia nervosa and bulimia nervosa), pregnancy or active attempts to conceive, known allergies or hypersensitivity to any components of the prescribed medications, and severe medical conditions such as a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, significant hepatic impairment, renal impairment requiring dialysis, uncontrolled cardiovascular diseases, or severe gastrointestinal disorders (eg, gastroparesis and pancreatitis)

Among them, retatrutide has shown significant clinical advantages in phase II clinical trials, reducing the weight of obese patients by up to 24.2% in 48 weeks and lowering the HbA1c of type 2 diabetes patients by 2.2% in 36 weeks (49, 50)

Liver Disease: Both Drugs May Reduce Risk Patients with Type 2 diabetes and chronic liver disease who took GLP-1s had a reduced risk of developing liver cancer and cirrhosisscarring of the livercompared to those who didnt take the drug, a Gut study found

Failure to protect against myocardial ischemia-reperfusion injury with sevoflurane postconditioning in old rats in vivo